PARIS, Dec. 6, 2013 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext:NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today, in accordance with its plans, the selection of its new product, NBTX-TOPO, in view of its preclinical development.
Help employers find you! Check out all the jobs and post your resume.
